Medtronic predicts FY 2025 EPS of 5.400-5.500 and revenue of $33.1bn-$33.6bn, with a consensus "Hold"
Medtronic (NYSE:MDT) announced its FY 2025 earnings guidance, predicting EPS of 5.400-5.500 and revenue of $33.1bn-$33.6bn. Analysts' consensus estimate for EPS is 5.440 and revenue is $33.4bn. Royal Bank of Canada rated MDT as sector perform with a $92.00 target, while UBS Group upped its target from $75.00 to $76.00 and gave a sell rating. Medtronic has a consensus "Hold" rating from 12 research firms, with an average 1-year price target of $91.09.
July 14, 2024
3 Articles